Piaggio & C (0FM1)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 1.949 |
|---|---|
| 52-week range | 1.396 – 2.035 |
| Return, 1 month / 3 months | +1.8% / +11.4% |
| Return, 1 year / 3 years | +3.7% / −34.1% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 28.2% |
| Worst drawdown (1 year) | -29.4% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Piaggio & C is an Italian maker of scooters, motorcycles and light commercial vehicles. Its scooters are sold under the Vespa and Piaggio names, while its small three- and four-wheeled goods and passenger vehicles carry the Ape and Porter badges. The company also produces motorcycle brands such as Aprilia, Moto Guzzi and Derbi. Customers range from everyday urban riders to small businesses needing compact transport. Piaggio is based in Pontedera, Italy, and sells its vehicles in many countries around the world.
Piaggio & C trades under the code 0FM1 on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Piaggio & C (0FM1) trades on the London Exchange in UK. It last closed at EUR 1.949 on 20 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 1,316 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.7% and over the last three months it rose 11.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.3% | ||
| From 52-week high | -4.0% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.4% | ||
| 6-month return | 31.7% | ||
| 12-month return, skipping the last month | 1.8% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.4% | ||
| Liquidity | 12 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 11.7% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | +1.8% |
| 3 months | +11.4% |
| 6 months | +31.7% |
| 1 year | +3.7% |
| 3 years | −34.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1.929 / 1.735 |
|---|---|
| Golden / death cross (60 days) | Golden, 46 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.031 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Sep 2026 | EUR 0.0570 |
| 22 Sep 2025 | EUR 0.0400 |
| 22 Apr 2025 | EUR 0.0400 |
| 23 Sep 2024 | EUR 0.1150 |
| 22 Apr 2024 | EUR 0.0800 |
| 18 Sep 2023 | EUR 0.1250 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.